CN100423740C - Oral and externally-applied Chinese medicinal preparation for treating osteoproliferation and its production - Google Patents
Oral and externally-applied Chinese medicinal preparation for treating osteoproliferation and its production Download PDFInfo
- Publication number
- CN100423740C CN100423740C CNB200610012785XA CN200610012785A CN100423740C CN 100423740 C CN100423740 C CN 100423740C CN B200610012785X A CNB200610012785X A CN B200610012785XA CN 200610012785 A CN200610012785 A CN 200610012785A CN 100423740 C CN100423740 C CN 100423740C
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine preparation
- crude drug
- radix
- orally taken
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A Chinese medicine in the form of powder for treating hyperosteogeny and rheumatic arthritis by both interior and exterior applications is prepared from 7 Chinese-medicinal materials including Chuan-xiong rhizome, acanthopanax bark, Chinese angelica root, safflower, etc through proportional mixing and pulverizing.
Description
Technical field
The present invention relates to a kind of Chinese medicine preparation and preparation method, particularly treat hyperosteogeny Chinese medicine preparation and preparation method, belong to medical technical field.
Background technology
Hyperosteogeny is called bony spur, hyperosteogeny again, is a kind of abnormality of skeleton, shows as skeleton and is growing, grows and finishing in the process of function, and some part loses normal form, occurs unusual.People with advancing age, the cartilage in joint is degenerated gradually, cell elasticity reduces, osteoarthrosis is being worn unconsciously, the especially neck that activity is big, waist, knee joint, heel, and the articular cartilage of damage is not when having blood vessel to supply with nutrition, just be difficult to repair, at this moment the peripheral blood recycle ratio in articular cartilage is more vigorous, the compensatory cartilage growth will occur, and is of long duration, outgrowth cartilage is again by calcification, form hyperosteogeny,, just be transformed into pathological state in case symptom occurs.Hyperosteogeny disease slower development, symptom often are gradual increasing the weight of, and arthralgia, numbness, swelling distortion, movable difficulty, function limitation appear in the patient, influence patient's quality of life, and disease serious person can lose the mobility teratogenesis or cause paralysis.Sickness rate accounts for 70% in this interior syndrome old group, wherein based on lumbar vertebra hyperosteogeny, secondly is hyperosteogeny, also has knee hyperplasia, heel hypertrophy, proliferative arthritis etc.Hyperosteogeny is a kind of degenerative disease, has certain degree of difficulty in the treatment, and western medical treatment generally is by agents alleviate and controlling symptoms, avoids the continuation development of pathological changes, and curative effect is unsatisfactory usually, and operative treatment is also arranged, but patient's compliance is poor.Integral viewpoint, determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs are particular about in treatment by Chinese herbs, but its weak point is also arranged, and the one, the medium-height grass prescription is many and mix, and the patient selects for use at a loss as to what to do and Time of Administration length takes effect slowly; The 2nd, lack that with strong points, curative effect is determined, internal and external application, the patent medicine preparation of working along both lines.
Summary of the invention
Technical problem to be solved by this invention is: provide a kind of evident in efficacy, cure rate is high, the Chinese medicine preparation and the preparation method of the Orally taken and externally of instant effect treatment hyperosteogeny.
Alleged problem of the present invention is solved by following technical scheme:
A kind of Orally taken and externally is treated the Chinese medicine preparation of hyperosteogeny, comprises the crude drug of following unit of weight in the composition: Rhizoma Chuanxiong 20～90, Cortex Acanthopancis 30～70, Herba speranskiae tuberculatae 20～70, Radix Angelicae Sinensis 20～80, Flos Carthami 10～60, Folium Artemisiae Argyi 30～180, Radix Dipsaci 10～70.
Above-mentioned Orally taken and externally is treated the Chinese medicine preparation of hyperosteogeny, comprises the crude drug of following unit of weight in the described Chinese medicine preparation: Rhizoma Corydalis 40～180.
Above-mentioned Orally taken and externally is treated the Chinese medicine preparation of hyperosteogeny, comprises the crude drug of following unit of weight in the described Chinese medicine preparation: Radix Saposhnikoviae 10～60.
Above-mentioned Orally taken and externally is treated the Chinese medicine preparation of hyperosteogeny, comprises the crude drug of following unit of weight in the described Chinese medicine preparation: Herba Schizonepetae 10～60, Radix Gentianae Macrophyllae 10～80.
The preparation method of the Chinese medicine preparation of above-mentioned Orally taken and externally treatment hyperosteogeny, it carries out as follows:
A. prepare burden: take by weighing each crude drug by the above-mentioned raw materials survival dose;
B. crushing screening mixes: each medicine mixes through rough pulverizing, levigate, collection medicated powder.
Medicament of the present invention, is groped through practice for many years with organic conception and determination of treatment based on pathogenesis obtained through differentiation of symptoms and signs principle understanding hyperosteogeny disease based on theory of Chinese medical science, determines the relation between flavour of a drug dosage and the compatibility, obtains one group of prescription of being made up of pure Chinese medicine.This medicament combination of inner and outside treatment hyperosteogeny, treatment by oral administration of medicines is based on promoting flow of QI and blood, dredge the meridian passage, increase immunity, remove the pathological change of stagnation of QI and blood may bring about pain, external treatment is with medicine and vinegar mixing, the heating back is applied and the affected part, and medicine sees through skin with the gaseous acid ion and combines acid-base neutralization with the calcium ion of bony spur, plays the minimizing calcium deposition, improve blood circulation, the effect of anti-inflammatory analgetic.This medicament is for oral administration to be used in combination with external, and treating both the principal and secondary aspects of a disease has rapid, the evident in efficacy characteristics of onset, through clinical observation, and cure rate 86.1%, produce effects 12.7%.Medicament of the present invention is through preparing burden, clean, making taking convenience, but long preservation behind the crushing screening.
The specific embodiment
The traditional Chinese medical science thinks that it is the endogenous cause of ill of hyperosteogeny morbidity that Liver and kidney weakness, body constitution descend, and treatment is worked as with promoting flow of QI and blood, and dredge the meridian passage increases immunity, eliminates aseptic inflammation, and the expansion canalis spinalis is removed the pathological change of stagnation of QI and blood may bring about pain.Prescription of the present invention, selected flavour of a drug prescription, for oral administration have a blood circulation promoting and blood stasis dispelling, removes the wind damp eliminating, the hard bone of the kidney invigorating, the effect of softening bony spur.In the drug prescription, Rhizoma Chuanxiong, the hot temperature of Rhizoma Corydalis, activating QI to alleviate the depression, dispeiling pathogenic wind and removing dampness, promoting blood circulation and stopping pain, be the major-minor medicine of wind-expelling pain-stopping, Herba speranskiae tuberculatae, Radix Saposhnikoviae, Radix Gentianae Macrophyllae, Herba Schizonepetae are good at the expelling wind and cold pain relieving, and Cortex Acanthopancis is good at removing dampness detumescence, wind-damp dispelling, bone and muscle strengthening in addition, can make the efficacy of a drug more very, help with Radix Angelicae Sinensis, Flos Carthami, Radix Dipsaci the promoting blood circulation to remove blood stasis collateral dredging of enriching blood, enhancing human body immunity power.All medicines share in the side, take mutually together, and the efficacy of a drug is single-minded, play the wind damp eliminating of loosing altogether, the merit of promoting the circulation of QI to relieve pain, nourishing blood and promoting blood circulation, detumescence dissipating blood stasis, expansion canalis spinalis.
During medicament external application of the present invention that medicine and vinegar blending and stirring is even, spread on the affected part after the heating, contain acid ion in the gas that the medicine heating is produced, with enter rapidly after the contact skin in the body local skeleton, produce neutralization reaction with calcium ion on the bony spur, and make that bony spur is softening, atrophy, absorption, and help inflammatory resolution, reduce calcium salt in tendon, ligament and periosteum place deposition, improve blood circulation.Both share medicine Orally taken and externally of the present invention, work along both lines, and treating both the principal and secondary aspects of a disease, thus reach significant curative effect.
Several embodiments of the present invention below are provided:
Embodiment 1: Rhizoma Chuanxiong 20, Cortex Acanthopancis 70, Herba speranskiae tuberculatae 30, Radix Angelicae Sinensis 80, Flos Carthami 10, Folium Artemisiae Argyi 30, Radix Dipsaci 40.
Embodiment 2: Rhizoma Chuanxiong 40, Cortex Acanthopancis 30, Herba speranskiae tuberculatae 70, Radix Angelicae Sinensis 20, Flos Carthami 60, Folium Artemisiae Argyi 80, Radix Dipsaci 10.
Embodiment 3: Rhizoma Chuanxiong 90, Cortex Acanthopancis 50, Herba speranskiae tuberculatae 20, Radix Angelicae Sinensis 40, Flos Carthami 40, Folium Artemisiae Argyi 180, Radix Dipsaci 70.
Embodiment 4: Rhizoma Chuanxiong 80, Cortex Acanthopancis 40, Herba speranskiae tuberculatae 30, Radix Angelicae Sinensis 50, Flos Carthami 30, Folium Artemisiae Argyi 60, Radix Dipsaci 30, Rhizoma Corydalis 40.
Embodiment 5: Rhizoma Chuanxiong 20, Cortex Acanthopancis 70, Herba speranskiae tuberculatae 40, Radix Angelicae Sinensis 30, Flos Carthami 30, Folium Artemisiae Argyi 120, Radix Dipsaci 20, Rhizoma Corydalis 180
Embodiment 6: Rhizoma Chuanxiong 70, Cortex Acanthopancis 60, Herba speranskiae tuberculatae 60, Radix Angelicae Sinensis 70, Flos Carthami 25, Folium Artemisiae Argyi 150, Radix Dipsaci 50, Radix Saposhnikoviae 10.
Embodiment 7: Rhizoma Chuanxiong 45, Cortex Acanthopancis 45, Herba speranskiae tuberculatae 50, Radix Angelicae Sinensis 55, Flos Carthami 50, Folium Artemisiae Argyi 70, Radix Dipsaci 15, Radix Saposhnikoviae 60.
Embodiment 8: Rhizoma Chuanxiong 30, Cortex Acanthopancis 30, Herba speranskiae tuberculatae 50, Radix Angelicae Sinensis 60, Flos Carthami 40, Folium Artemisiae Argyi 100, Radix Dipsaci 40, Rhizoma Corydalis 100, Radix Saposhnikoviae 50.
Embodiment 9: Rhizoma Chuanxiong 90, Cortex Acanthopancis 70, Herba speranskiae tuberculatae 70, Radix Angelicae Sinensis 20, Flos Carthami 60, Folium Artemisiae Argyi 180, Radix Dipsaci 70, Rhizoma Corydalis 40, Radix Saposhnikoviae 20.
Embodiment 10: Rhizoma Chuanxiong 50, Cortex Acanthopancis 30, Herba speranskiae tuberculatae 60, Radix Angelicae Sinensis 50, Flos Carthami 40, Folium Artemisiae Argyi 60, Radix Dipsaci 10, Rhizoma Corydalis 60, Radix Saposhnikoviae 30, Herba Schizonepetae 60, Radix Gentianae Macrophyllae 10.
Embodiment 11: Rhizoma Chuanxiong 60, Cortex Acanthopancis 50, Herba speranskiae tuberculatae 50, Radix Angelicae Sinensis 80, Flos Carthami 10, Folium Artemisiae Argyi 180, Radix Dipsaci 70, Rhizoma Corydalis 50, Radix Saposhnikoviae 10, Herba Schizonepetae 30, Radix Gentianae Macrophyllae 50.
Embodiment 12: Rhizoma Chuanxiong 90, Cortex Acanthopancis 30～70, Herba speranskiae tuberculatae 60, Radix Angelicae Sinensis 20, Flos Carthami 60, Folium Artemisiae Argyi 120, Radix Dipsaci 50, Rhizoma Corydalis 40, Radix Saposhnikoviae 60, Herba Schizonepetae 10, Radix Gentianae Macrophyllae 80.
Preparation method: take by weighing each crude drug by the above-mentioned raw materials survival dose; Each medicine mixes through rough pulverizing, levigate, collection medicated powder, makes powder.
Every day twice for oral administration, each 6～8 grams.
Powder 44 grams are got in external application, join vinegar 98 grams, put into the ferrum spoon simultaneously and stir, and make popular on the fire, all absorb in the medicated powder to vinegar, in the cloth bag of packing into, spread on the affected part, add a small amount of vinegar after the medicated bag cold again, make popular and spread on the affected part, repeatedly repeatedly, external application every day one is to secondary, each 1.5 to 2 hours.
Medicament of the present invention takes 45 days courses of treatment orally, 30 days courses of treatment of external application, course of treatment of the lighter; Heavy person can cure two courses of treatment.Clinical observation, cure rate 86.1%, produce effects 12.7%, and for the treatment rheumatic arthritis certain curative effect is arranged.
Claims (6)
1. the Chinese medicine preparation of an Orally taken and externally treatment hyperosteogeny is characterized in that, comprises the crude drug of following unit of weight in the composition: Rhizoma Chuanxiong 20～90, Cortex Acanthopancis 30～70, Herba speranskiae tuberculatae 20～70, Radix Angelicae Sinensis 20～80, Flos Carthami 10～60, Folium Artemisiae Argyi 30～180, Radix Dipsaci 10～70.
2. the Chinese medicine preparation of Orally taken and externally treatment hyperosteogeny according to claim 1 is characterized in that: the crude drug that comprises following unit of weight in the described Chinese medicine preparation: Rhizoma Corydalis 40～180.
3. the Chinese medicine preparation of Orally taken and externally treatment hyperosteogeny according to claim 1 and 2 is characterized in that: the crude drug that comprises following unit of weight in the described Chinese medicine preparation: Radix Saposhnikoviae 10～60.
4. the Chinese medicine preparation of Orally taken and externally treatment hyperosteogeny according to claim 1 and 2 is characterized in that: the crude drug that comprises following unit of weight in the described Chinese medicine preparation: Herba Schizonepetae 10～60, Radix Gentianae Macrophyllae 10～80.
5. the Chinese medicine preparation of Orally taken and externally treatment hyperosteogeny according to claim 3 is characterized in that: the crude drug that comprises following unit of weight in the described Chinese medicine preparation: Herba Schizonepetae 10～60, Radix Gentianae Macrophyllae 10～80.
6. according to the preparation method of the Chinese medicine preparation of claim 1 or 2 or 3 or 4 or 5 described Orally taken and externallies treatment hyperosteogenys, it is characterized in that it carries out as follows:
A. prepare burden: take by weighing each crude drug by the above-mentioned raw materials survival dose;
B. crushing screening mixes: each medicine mixes through rough pulverizing, levigate, collection medicated powder.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200610012785XA CN100423740C (en) | 2006-06-05 | 2006-06-05 | Oral and externally-applied Chinese medicinal preparation for treating osteoproliferation and its production |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200610012785XA CN100423740C (en) | 2006-06-05 | 2006-06-05 | Oral and externally-applied Chinese medicinal preparation for treating osteoproliferation and its production |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1895332A CN1895332A (en) | 2007-01-17 |
| CN100423740C true CN100423740C (en) | 2008-10-08 |
Family
ID=37608070
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200610012785XA Active CN100423740C (en) | 2006-06-05 | 2006-06-05 | Oral and externally-applied Chinese medicinal preparation for treating osteoproliferation and its production |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100423740C (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103083378B (en) * | 2012-11-25 | 2014-06-11 | 溧阳市天目湖保健品有限公司 | Chinese medicinal composition for treating hyperosteogeny and preparation method thereof |
| CN102988463A (en) * | 2012-12-27 | 2013-03-27 | 马培洪 | Fumigation medicament for treating cervical spondylosis |
| CN103070965B (en) * | 2013-02-05 | 2014-01-08 | 山东大学 | Chinese traditional medicine for relieving swelling and pain and promoting blood circulation to remove meridian obstruction |
| CN103191305A (en) * | 2013-02-25 | 2013-07-10 | 孙胜波 | Traditional Chinese medicine composition for treating hyperosteogeny |
| CN103142764B (en) * | 2013-03-01 | 2014-08-13 | 溧阳市天目湖保健品有限公司 | Traditional Chinese medicine composition for treating soft tissue contusion and preparation method of traditional Chinese medicine composition |
| CN104257965A (en) * | 2014-09-25 | 2015-01-07 | 周红玲 | Traditional Chinese medicine for treating knee joint hyperostosis via oral and external administration and preparation method thereof |
| CN104324322A (en) * | 2014-10-11 | 2015-02-04 | 长春中医药大学 | Externally-applied traditional Chinese medicine composition for treating liver and kidney two-deficiency knee osteoarthritis |
| CN104398745A (en) * | 2014-12-07 | 2015-03-11 | 王月水 | Traditional Chinese medicinal bath for treating neck-shoulder and lumbocrural pain and lubar intervertebral disc prolapse and preparation method for traditional Chinese medicinal bath |
| CN104606384A (en) * | 2015-03-09 | 2015-05-13 | 济南方宇文化传媒有限公司 | Composition for treating back and leg pain and preparation method for composition |
| CN108272906A (en) * | 2018-02-08 | 2018-07-13 | 珠海宝石康科技有限公司 | A kind of fire aerolite wine and preparation method thereof |
| CN111097003A (en) * | 2018-10-25 | 2020-05-05 | 赵石军 | Medicament for treating lumbocrural pain |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1329895A (en) * | 2000-06-27 | 2002-01-09 | 王喜 | Exterior-applied ointment for treating hyperosteogeny |
| CN1465385A (en) * | 2002-06-21 | 2004-01-07 | 程光智 | Chinese medicine for treating lumbar vertebrae hyperosteogeny |
-
2006
- 2006-06-05 CN CNB200610012785XA patent/CN100423740C/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1329895A (en) * | 2000-06-27 | 2002-01-09 | 王喜 | Exterior-applied ointment for treating hyperosteogeny |
| CN1465385A (en) * | 2002-06-21 | 2004-01-07 | 程光智 | Chinese medicine for treating lumbar vertebrae hyperosteogeny |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1895332A (en) | 2007-01-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100423740C (en) | Oral and externally-applied Chinese medicinal preparation for treating osteoproliferation and its production | |
| CN102309644A (en) | Traditional Chinese medical composition for treating bone fracture | |
| CN100394955C (en) | Chinese traditional medicine preparation for treating bone fracture and traumatic injury | |
| CN101366845A (en) | Ointment for treating ache of neck, shoulder, waist and leg | |
| CN102309723A (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method of ointment thereof | |
| CN101417003A (en) | Traditional Chinese medicine composition for treating vertebras disease | |
| CN103432551A (en) | Externally applied medicine for treating scapulohumeral periarthritis, radiohumeral bursitis and inexplicable ostalgia | |
| CN104922363A (en) | Traditional Chinese medicine composite for treating osteoproliferation | |
| CN101433647B (en) | Plaster for treating femoral head necrosis and preparation method thereof | |
| CN101708292B (en) | Chinese medicament for treating rheumatic and rheumatoid diseases | |
| CN102302571B (en) | Chinese medicinal composition for treating bony spur diseases and preparation method and application thereof | |
| CN105770847A (en) | Traditional Chinese medicine composition for relieving or treating joint swelling and pain and preparation method and application of traditional Chinese medicine composition | |
| CN100486640C (en) | Externally applied medicine for treating neck and waist arthrosis | |
| CN110538272A (en) | swelling-reducing and collateral-dredging powder for treating soft tissue injury and joint swelling and pain and preparation method thereof | |
| CN104758412A (en) | Traditional Chinese medicine composition for treating degenerative gonarthrosis as well as clinic preparation and preparation method of traditional Chinese medicine composition | |
| CN101057957A (en) | External applied traditional Chinese medicine lotion for treating osteoproliferation and bony spur | |
| CN104189345A (en) | Externally applied traditional Chinese medicine plaster for treating aching diseases | |
| CN103070997A (en) | Drug for curing ischialgia and preparing method thereof | |
| CN103656309B (en) | A kind of fracture/bone splits healing ancillary drug compositions | |
| CN100434103C (en) | Chinese medicine composition for treating anemogenous-ache disease | |
| CN108888736B (en) | External-use bone reunion medicine and preparation method thereof | |
| CN104208207A (en) | Externally applied traditional Chinese medicine plaster for treating lumbago | |
| CN105560537A (en) | Medicine composition for treating osteoartritis and preparation method thereof | |
| CN106266153A (en) | A kind of for Chinese medicine composition dredging collaterals of human and preparation method thereof | |
| CN105343771A (en) | Novel traditional Chinese medicine for treating cervical and lumbar degenerative disease and preparation technology thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |